ICON plc | Clinical Research Organisation (CRO) for Drug Development

The key to remarkable rare disease registries

Building trust and collaboration with patient advocacy organisations

Effective participation support strategy is critical to trial efficiency

Critical success factors for rare disease clinical trials

Spotlight on regulatory reforms in China

Although China’s regulatory reforms have attracted many foreign companies to conduct trials in China, there are still challenges.

Transfer of marketing authorisation

Navigating the transfer regulatory procedure for biopharma

Featured Services

Seeking parallel consultation from regulators and HTA bodies in Europe

Market Access

Expertise in mission-critical pricing, market access, and reimbursement.

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

18 January 2023

The importance of developing rTPP to build biotech asset value

Discover how Biotechs can build value into their asset by developing a reimbursable Target Product Profile (rTPP).

13 January 2023

The impact of real world evidence on drug marketing approval and reimbursement

Increasing use of real world data and real world evidence for market regulatory decisions can lead to a more holistic understanding of safety and potency factors for healthcare practices.

06 January 2023

Redefining sourcing model terminology

This blog explores the new framework for defining CRO sourcing models and explains its importance.

20 December 2022

Optimising biotech trial designs to stretch your cash runway

Read this blog to learn a few key considerations to help optimise and de-risk your trial design.

19 December 2022

Crafting a competitive biotech funding pitch

Biotechs can hone their pitch with the guidelines provided in this blog and through early engagement opportunities with strategic partners.

15 December 2022

Medical device classifications and applicable Food and Drug Administration regulations

Medical device manufacturers should understand how their product is viewed by regulatory bodies to proceed with the appropriate regulatory pathway to market.

14 December 2022

Filling the gaps for rare and orphan diseases

Read the blog to learn more about the benefits and challenges of Rare Disease natural history studies.

06 December 2022

Pharmacovigilance outsourcing: Tips for selecting a service provider

Selecting a vendor requires careful exploration and planning to ensure a successful relationship between sponsor and outsourcing partner.

05 December 2022

MDR transition period and certification bottleneck

It is of paramount importance that companies with expiring certification begin the process to remain compliant under the new MDR. Read more about identified challenges and solutions.

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

Healthcare Intelligence

Sponsor and CRO pharmacovigilance and safety alliances

Beyond buzzwords: Diversity, equity and inclusion in rare disease clinical trials

Fortifying vaccines